EUVIMEDEUVIMED entdecken
Fallbericht

Carbamazepine-Induced Paroxysmal Dysarthria and Ataxia in an Elderly Patient: A Case Report and Clinical Considerations

Fayuan Ji, Dongmei Wu, Chao He, Yang Si, Hongbin Sun

Neurotoxicity Research · 2026-08 · 44 (4)

DOI: 10.1007/s12640-026-00803-4 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Neurotoxicity Research, online erschienen am 19.06.2026. Verfasst von Fayuan Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Zizhong People's Hospital, Neijiang, Sichuan Province, China. Hauptthemen laut MEDLINE: Dysarthria, Ataxia, Carbamazepine, Anticonvulsants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 15 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

To report a case of carbamazepine-induced neurotoxicity presenting as paroxysmal dysarthria with ataxia, and to highlight clinical risk factors and diagnostic challenges. This case mimicked a transient ischemic attack (TIA), representing a significant diagnostic pitfall. We present the case of a 71-year-old woman who developed acute paroxysmal dysarthria and ataxia after initiating carbamazepine for otoneuralgia. Differential diagnoses considered included TIA, seizure, drug-induced neurotoxicity, and vestibular disorders. Diagnosis was established through medication review, temporal correlation, and a positive rechallenge test. The Naranjo Adverse Drug Reaction Probability Scale was applied. Symptoms resolved completely upon drug withdrawal and recurred immediately after re-exposure (the patient self-administered a single 100 mg dose on day 4, with immediate symptom recurrence, confirming causality). Serum drug levels were not measured due to limitations of our hospital's laboratory facilities; the Naranjo score was 5 (probable ADR). This case illustrates that carbamazepine may induce specific neurotoxicity even at standard doses in susceptible elderly patients. Paroxysmal dysarthria is a rare but underrecognized adverse reaction. Key clinical take-home points include vigilant clinical assessment, caution with potential drug-drug interactions, therapeutic drug monitoring, and pharmacogenetic profiling when indicated- all of which may aid in prevention and risk reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DysarthriaAtaxiaCarbamazepineAnticonvulsantsHumansFemaleAged

Stichwörter der Autor:innen

Adverse Drug ReactionCarbamazepineDysarthriaNeurotoxicityPharmacogenetics

Substanzen

CarbamazepineAnticonvulsants

Autor:innen und Institutionen

  • Department of Surgery, Zizhong People's Hospital, Neijiang, Sichuan Province, China.
  • Department of Neurology, Zizhong People's Hospital, Neijiang, Sichuan Province, China. 1223183087@qq.com.
  • Department of Neurology, Zizhong People's Hospital, Neijiang, Sichuan Province, China.
  • Department of Neurology, Sichuan Academy of Medical Sciences, Sichuan People's Hospital, Chengdu, Sichuan Province, China.

Zitieren

APA

Ji, F., Wu, D., He, C., Si, Y., & Sun, H. (2026). Carbamazepine-Induced Paroxysmal Dysarthria and Ataxia in an Elderly Patient: A Case Report and Clinical Considerations. Neurotoxicity Research, 44(4). https://doi.org/10.1007/s12640-026-00803-4

Vancouver

Ji F, Wu D, He C, Si Y, Sun H. Carbamazepine-Induced Paroxysmal Dysarthria and Ataxia in an Elderly Patient: A Case Report and Clinical Considerations. Neurotoxicity Research. 2026;44(4). doi:10.1007/s12640-026-00803-4

BibTeX
@article{Ji2026,
  author = {Ji, Fayuan and Wu, Dongmei and He, Chao and Si, Yang and Sun, Hongbin},
  title = {Carbamazepine-Induced Paroxysmal Dysarthria and Ataxia in an Elderly Patient: A Case Report and Clinical Considerations},
  journal = {Neurotoxicity Research},
  year = {2026},
  volume = {44},
  number = {4},
  doi = {10.1007/s12640-026-00803-4}
}
Kostenlos starten →